In our study, we observed that decreased SPARC expression in lung cancer cell lines is associated with DNA methylation of the gene promoter, and it is re-expressed by treatment with the demethylating agent 5-Aza-CdR in lung cancer cell lines. This evidence concerns the gene SPARC and lung cancer.